07:00 , Jul 9, 2009 |  BC Innovations  |  Cover Story

Anexon's fail-safe BNP

Researchers at the Mayo Clinic and University of Minnesota have identified an alternatively spliced form of the hormone B-type natriuretic peptide that lacks the blood pressure-lowering effects that have curtailed the use of its regular...
07:00 , Jun 25, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Heart failure Unknown Studies in canines and in tissue culture suggest that a modified B-type natriuretic peptide (ASBNP.1) could help treat heart failure with...